Medincell SA
PAR:MEDCL
Medincell SA
PAR:MEDCL
Price:
20.34
EUR
-2.21%
Market Closed
Market Cap:
€678.3m
Balance Sheet
Balance Sheet Decomposition
Medincell SA
Medincell SA
Balance Sheet Decomposition is not available for
Medincell SA
Medincell SA
Balance Sheet
Medincell SA
Medincell SA
Currency: EUR
| Mar-2017 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
4
|
21
|
12
|
47
|
25
|
6
|
19
|
22
|
|
| Cash |
0
|
6
|
8
|
44
|
20
|
6
|
14
|
18
|
|
| Cash Equivalents |
4
|
15
|
4
|
3
|
5
|
0
|
5
|
4
|
|
| Short-Term Investments |
5
|
1
|
0
|
4
|
3
|
0
|
0
|
50
|
|
| Total Receivables |
1
|
3
|
4
|
5
|
6
|
12
|
7
|
8
|
|
| Accounts Receivables |
1
|
0
|
1
|
1
|
1
|
2
|
1
|
1
|
|
| Other Receivables |
0
|
3
|
4
|
4
|
5
|
11
|
5
|
6
|
|
| Inventory |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
3
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Total Current Assets |
14
|
26
|
18
|
56
|
34
|
20
|
27
|
81
|
|
| PP&E Net |
2
|
3
|
4
|
4
|
7
|
6
|
5
|
5
|
|
| PP&E Gross |
0
|
3
|
4
|
4
|
7
|
6
|
5
|
5
|
|
| Accumulated Depreciation |
0
|
2
|
2
|
3
|
4
|
5
|
5
|
6
|
|
| Intangible Assets |
2
|
1
|
2
|
1
|
2
|
2
|
2
|
3
|
|
| Long-Term Investments |
3
|
5
|
4
|
2
|
2
|
1
|
2
|
2
|
|
| Other Long-Term Assets |
3
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
23
N/A
|
38
+63%
|
27
-28%
|
64
+133%
|
44
-30%
|
29
-34%
|
37
+26%
|
90
+145%
|
|
| Liabilities | |||||||||
| Accounts Payable |
2
|
2
|
3
|
3
|
3
|
4
|
2
|
4
|
|
| Accrued Liabilities |
0
|
1
|
1
|
2
|
1
|
3
|
3
|
5
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
1
|
3
|
1
|
3
|
28
|
40
|
6
|
7
|
|
| Other Current Liabilities |
3
|
1
|
1
|
6
|
6
|
10
|
5
|
14
|
|
| Total Current Liabilities |
5
|
8
|
7
|
14
|
38
|
57
|
16
|
30
|
|
| Long-Term Debt |
20
|
24
|
31
|
39
|
19
|
14
|
53
|
51
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
5
|
2
|
0
|
0
|
9
|
25
|
|
| Total Liabilities |
26
N/A
|
32
+24%
|
43
+36%
|
54
+26%
|
58
+6%
|
72
+24%
|
78
+9%
|
107
+37%
|
|
| Equity | |||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
0
|
27
|
49
|
66
|
21
|
50
|
72
|
87
|
|
| Additional Paid In Capital |
0
|
33
|
33
|
75
|
7
|
7
|
31
|
71
|
|
| Other Equity |
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
2
N/A
|
6
N/A
|
16
N/A
|
9
N/A
|
13
N/A
|
42
-216%
|
41
+3%
|
16
+60%
|
|
| Total Liabilities & Equity |
23
N/A
|
38
+63%
|
27
-28%
|
64
+133%
|
44
-30%
|
29
-34%
|
37
+26%
|
90
+145%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
14
|
20
|
20
|
25
|
25
|
25
|
29
|
33
|
|
Switch to:
Switch to:
See Also
Discover More
